Noor A. Lokman

2.0k total citations
42 papers, 1.4k citations indexed

About

Noor A. Lokman is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Noor A. Lokman has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Noor A. Lokman's work include S100 Proteins and Annexins (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cancer Cells and Metastasis (5 papers). Noor A. Lokman is often cited by papers focused on S100 Proteins and Annexins (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cancer Cells and Metastasis (5 papers). Noor A. Lokman collaborates with scholars based in Australia, Malaysia and Japan. Noor A. Lokman's co-authors include Carmela Ricciardelli, Martin K. Oehler, Miranda P. Ween, Alison S. F. Elder, Peter Hoffmann, Carmen E. Pyragius, A. MacPherson, Andrew Ruszkiewicz, Manuela Klingler‐Hoffmann and Raymond J. Rodgers and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Noor A. Lokman

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noor A. Lokman Australia 20 869 357 342 219 176 42 1.4k
Saiful Effendi Syafruddin Malaysia 16 593 0.7× 253 0.7× 199 0.6× 126 0.6× 146 0.8× 40 992
Jean‐Paul Brouillet France 21 800 0.9× 615 1.7× 639 1.9× 110 0.5× 136 0.8× 33 1.7k
Letícia Batista Azevedo Rangel Brazil 14 568 0.7× 280 0.8× 284 0.8× 129 0.6× 127 0.7× 39 1.1k
Mathieu Boissan France 25 1.3k 1.5× 169 0.5× 319 0.9× 162 0.7× 213 1.2× 52 1.9k
Yubin Mao China 18 1.1k 1.3× 502 1.4× 687 2.0× 102 0.5× 220 1.3× 23 2.0k
Lluís López-Barcons United States 16 742 0.9× 186 0.5× 305 0.9× 103 0.5× 136 0.8× 44 1.3k
Radosław Januchowski Poland 24 1.1k 1.2× 476 1.3× 736 2.2× 143 0.7× 224 1.3× 53 1.8k
Venkatesh Krishnan United States 20 1.1k 1.2× 285 0.8× 758 2.2× 153 0.7× 961 5.5× 35 2.3k
Michael Jansen United States 20 947 1.1× 204 0.6× 255 0.7× 99 0.5× 210 1.2× 48 1.7k
M. Aiman Mohtar Malaysia 16 618 0.7× 164 0.5× 187 0.5× 230 1.1× 145 0.8× 26 1.0k

Countries citing papers authored by Noor A. Lokman

Since Specialization
Citations

This map shows the geographic impact of Noor A. Lokman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noor A. Lokman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noor A. Lokman more than expected).

Fields of papers citing papers by Noor A. Lokman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noor A. Lokman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noor A. Lokman. The network helps show where Noor A. Lokman may publish in the future.

Co-authorship network of co-authors of Noor A. Lokman

This figure shows the co-authorship network connecting the top 25 collaborators of Noor A. Lokman. A scholar is included among the top collaborators of Noor A. Lokman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noor A. Lokman. Noor A. Lokman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wanqi, Veronika Bandara, Noor A. Lokman, et al.. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. Cancer Research. 84(6_Supplement). 6320–6320.
3.
Lokman, Noor A., Mai Sugiyama, Yoshihiro Koya, et al.. (2023). Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer. Cellular and Molecular Life Sciences. 80(11). 320–320. 2 indexed citations
4.
Arentz, Georgia, Parul Mittal, Manuela Klingler‐Hoffmann, et al.. (2023). Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer. Cancers. 15(7). 2172–2172. 5 indexed citations
5.
Wang, Wanqi, Veronika Bandara, Noor A. Lokman, et al.. (2022). Abstract 5183: LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer. Cancer Research. 82(12_Supplement). 5183–5183. 4 indexed citations
6.
Leung, Dilys T.H., Noor A. Lokman, Wanqi Wang, et al.. (2022). Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism. Journal of Translational Medicine. 20(1). 556–556. 24 indexed citations
7.
Lokman, Noor A., et al.. (2022). Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways. International Journal of Molecular Sciences. 24(1). 696–696. 10 indexed citations
8.
Lokman, Noor A., Bryden C. Quirk, Loretta Scolaro, et al.. (2021). Optical Fibre-Enabled Photoswitching for Localised Activation of an Anti-Cancer Therapeutic Drug. International Journal of Molecular Sciences. 22(19). 10844–10844. 8 indexed citations
9.
Wang, Wanqi, et al.. (2021). ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. Cancer Drug Resistance. 4(2). 485–502. 17 indexed citations
10.
Weiland, Florian, Noor A. Lokman, Manuela Klingler‐Hoffmann, et al.. (2020). Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer. Frontiers in Oncology. 10. 1767–1767. 10 indexed citations
11.
Tadesse, Solomon, Mingfeng Yu, Benjamin Noll, et al.. (2020). A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer. Gynecologic Oncology. 159(3). 827–838. 12 indexed citations
12.
Høgdall, Claus, Steffen Grann Jensen, Noor A. Lokman, et al.. (2019). Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer. Anticancer Research. 39(5). 2475–2482. 10 indexed citations
13.
Lokman, Noor A., et al.. (2019). 4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer. Cancers. 11(8). 1187–1187. 35 indexed citations
14.
Ricciardelli, Carmela, Noor A. Lokman, Wendy M. Bonner, et al.. (2018). Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics. Cancer Letters. 421. 51–58. 37 indexed citations
15.
Zhu, Wenying, Kate E. Jarman, Noor A. Lokman, et al.. (2017). CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1. Cancer Research. 77(18). 4823–4834. 24 indexed citations
16.
Tarulli, Gerard A., Lei Sheng, Noor A. Lokman, et al.. (2017). Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer. Oncogene. 36(31). 4469–4480. 36 indexed citations
17.
Ricciardelli, Carmela, Noor A. Lokman, Miranda P. Ween, & Martin K. Oehler. (2016). WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer–peritoneal cell interactions promote extracellular matrix processing. Endocrine Related Cancer. 23(11). T155–T168. 24 indexed citations
18.
Ricciardelli, Carmela, et al.. (2013). Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer. BMC Cancer. 13(1). 476–476. 72 indexed citations
19.
Lokman, Noor A., Alison S. F. Elder, Miranda P. Ween, et al.. (2013). Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget. 4(8). 1199–1211. 55 indexed citations
20.
Lokman, Noor A., Miranda P. Ween, Martin K. Oehler, & Carmela Ricciardelli. (2011). The Role of Annexin A2 in Tumorigenesis and Cancer Progression. Cancer Microenvironment. 4(2). 199–208. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026